ECM
PTCT icon

ExodusPoint Capital Management’s PTC Therapeutics PTCT Stock Holding History

ExodusPoint Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,057
Closed -$840K – 1993
2025
Q4 		$840K Sell
11,057
-62,401
-85% -$4.53M 0.01% 1054
2025
Q3 		$4.51M Buy
+73,458
New +$3.83M 0.05% 450
2024
Q3 		– Sell
-68,020
Closed -$2.08M – 2004
2024
Q2 		$2.08M Buy
+68,020
New +$2.2M 0.01% 762
2023
Q4 		– Sell
-23,483
Closed -$526K – 1940
2023
Q3 		$526K Sell
23,483
-41,599
-64% -$1.55M 0.01% 1226
2023
Q2 		$2.65M Buy
+65,082
New +$3.18M 0.02% 698
2023
Q1 		– Sell
-7,466
Closed -$285K – 2058
2022
Q4 		$285K Sell
7,466
-34,254
-82% -$1.42M ﹤0.01% 1369
2022
Q3 		$2.09M Buy
41,720
+29,290
+236% +$1.44M 0.03% 785
2022
Q2 		$498K Buy
+12,430
New +$436K 0.01% 1352
2021
Q3 		– Sell
-9,524
Closed -$403K – 2524
2021
Q2 		$403K Buy
9,524
+1,446
+18% +$62K ﹤0.01% 1562
2021
Q1 		$382K Buy
+8,078
New +$480K 0.01% 1522
2019
Q4 		– Sell
-6,000
Closed -$203K – 1816
2019
Q3 		$203K Buy
+6,000
New +$261K 0.01% 1119

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ExodusPoint Capital Management's PTCT Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of PTC Therapeutics (PTCT) in Q1 2026, closing a stake of 11,057 shares — an estimated $840K sold.

ExodusPoint Capital Management first reported a position in PTCT in Q3 2019 and held it in 11 quarters. The position peaked at $4.51M in Q3 2025. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining PTC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 11,057 PTC Therapeutics shares in Q1 2026, an estimated $840K.
  • ExodusPoint Capital Management first reported a position in PTC Therapeutics in Q3 2019 and held it in 11 quarters.
  • ExodusPoint Capital Management's PTC Therapeutics position peaked at $4.51M in Q3 2025.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.